Get Started

GLPG

Galapagos (GLPG)

Galapagos

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:EU:GLPG

<< Previous 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next >>

Date	Time	Source	Headline	Symbol	Company
10/31/2019	4:01PM	GlobeNewswire Inc.	GILEAD AND GALAPAGOS TO PRESENT NEW DATA ON FILGOTINIB AT 2019 ACR/ARP ANNUAL MEETING	EU:GLPG	Galapagos
10/31/2019	4:01PM	GlobeNewswire Inc.	GILEAD AND GALAPAGOS TO PRESENT NEW DATA ON FILGOTINIB AT 2019 ACR/ARP ANNUAL MEETING	EU:GLPG	Galapagos
10/28/2019	4:45PM	GlobeNewswire Inc.	MOR106 clinical development in atopic dermatitis stopped for futility	EU:GLPG	Galapagos
10/28/2019	4:45PM	GlobeNewswire Inc.	MOR106 clinical development in atopic dermatitis stopped for futility	EU:GLPG	Galapagos
10/25/2019	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from Wellington Management Group LLP	EU:GLPG	Galapagos
10/25/2019	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from Wellington Management Group LLP	EU:GLPG	Galapagos
10/24/2019	4:01PM	GlobeNewswire Inc.	Solid third quarter 2019 performance with strong balance sheet for continued R&D growth	EU:GLPG	Galapagos
10/24/2019	4:01PM	GlobeNewswire Inc.	Solid third quarter 2019 performance with strong balance sheet for continued R&D growth	EU:GLPG	Galapagos
10/10/2019	7:10PM	Dow Jones News	Gilead Sciences, Galapagos See Efficacy in Advanced Rheumatoid Arthritis Study	EU:GLPG	Galapagos
10/10/2019	6:00PM	GlobeNewswire Inc.	GILEAD AND GALAPAGOS ANNOUNCE EFFICACY AND SAFETY RESULTS OF FILGOTINIB THROUGH 52 WEEKS IN FINCH 1 AND FINC...	EU:GLPG	Galapagos
10/10/2019	6:00PM	GlobeNewswire Inc.	GILEAD AND GALAPAGOS ANNOUNCE EFFICACY AND SAFETY RESULTS OF FILGOTINIB THROUGH 52 WEEKS IN FINCH 1 AND FINC...	EU:GLPG	Galapagos
10/07/2019	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from Wellington Management Group LLP	EU:GLPG	Galapagos
10/07/2019	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from Wellington Management Group LLP	EU:GLPG	Galapagos
09/24/2019	4:01PM	GlobeNewswire Inc.	Galapagos initiates Phase 1 trial for second Toledo compound	EU:GLPG	Galapagos
09/24/2019	4:01PM	GlobeNewswire Inc.	Galapagos initiates Phase 1 trial for second Toledo compound	EU:GLPG	Galapagos
09/20/2019	4:53PM	GlobeNewswire Inc.	Invitation to the special and extraordinary shareholders' meetings	EU:GLPG	Galapagos
09/20/2019	4:53PM	GlobeNewswire Inc.	Invitation to the special and extraordinary shareholders' meetings	EU:GLPG	Galapagos
09/20/2019	4:01PM	GlobeNewswire Inc.	Invitation to the special and extraordinary shareholders' meetings	EU:GLPG	Galapagos
09/20/2019	4:01PM	GlobeNewswire Inc.	Invitation to the special and extraordinary shareholders' meetings	EU:GLPG	Galapagos
09/19/2019	4:01PM	GlobeNewswire Inc.	Transparency notification	EU:GLPG	Galapagos
09/19/2019	4:01PM	GlobeNewswire Inc.	Transparency notification	EU:GLPG	Galapagos
09/19/2019	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through warrant exercises	EU:GLPG	Galapagos
09/19/2019	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through warrant exercises	EU:GLPG	Galapagos
08/30/2019	4:01PM	GlobeNewswire Inc.	Transparency notification	EU:GLPG	Galapagos
08/30/2019	4:01PM	GlobeNewswire Inc.	Transparency notification	EU:GLPG	Galapagos
08/28/2019	4:01PM	GlobeNewswire Inc.	Transparency notification – Gilead holds 22% of Galapagos shares	EU:GLPG	Galapagos
08/28/2019	4:01PM	GlobeNewswire Inc.	Transparency notification – Gilead holds 22% of Galapagos shares	EU:GLPG	Galapagos
08/23/2019	4:01PM	GlobeNewswire Inc.	Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration	EU:GLPG	Galapagos
08/23/2019	4:01PM	GlobeNewswire Inc.	Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration	EU:GLPG	Galapagos
08/15/2019	5:23PM	Dow Jones News	European Medicines Agency Reviews Arthritis Treatment by Gilead, Galapagos	EU:GLPG	Galapagos